Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
-- The first FDA-approved oral GLP-1 for weight loss
This advanced 3-in-1 formula helps curb unwanted hunger, fire up calorie burning, and deliver smooth, sustained energy without the jitter - bringing you closer to a leaner, more confident physique.*
We performed a network meta-analysis to compare the effect on cardiorenal outcomes among GLP-1 RAs, SGLT-2 inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors
No compounded solutions are offered in our prescriptions
The semaglutide component follows the same dose escalation schedule as standard compounded semaglutide: Weeks 1-4: 0.25 mg semaglutide (0.1 mL) Weeks 5-8: 0.5 mg semaglutide (0.2 mL) Weeks 9-12: 1.0 mg semaglutide (0.4 mL) Weeks 13-16: 1.7 mg semaglutide (0.68 mL) Week 17+: 2.4 mg semaglutide (0.96 mL) The niacinamide dose scales proportionally with the injection volume
